A genomic and evolutionary approach reveals non-genetic drug resistance in malaria by Rice, Daniel P., Ribacke, Ulf, Silterra, Jacob, Deik, Amy A., Moss, Eli L., Broadbent, Kate M., Neafsey, Daniel E., Desai, Michael M., Clish, Clary, Mazitschek, Ralph, Wirth, Dyann F., Herman, Jonathan D.

Get full text
Get full text

Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response by Herman, Jonathan D, Wang, Chuangqi, Loos, Carolin, Yoon, Hyunah, Rivera, Johanna, Eugenia Dieterle, M, Haslwanter, Denise, Jangra, Rohit K, Bortz, Robert H, Bar, Katharine J, Julg, Boris, Chandran, Kartik, Lauffenburger, Douglas, Pirofski, Liise-anne, Alter, Galit

Get full text

Nucleocapsid-specific antibody function is associated with therapeutic benefit from Covid-19 Convalescent plasma therapy by Herman, Jonathan D, Wang, Chuangqi, Burke, John Stephen, Zur, Yonatan, Compere, Hacheming, Kang, Jaewon, Macvicar, Ryan, Taylor, Sabian, Shin, Sally, Frank, Ian, Siegel, Don, Tebas, Pablo, Choi, Grace H, Shaw, Pamela A, Yoon, Hyunah, Pirofski, Liise-anne, Julg, Boris D, Bar, Katharine J, Lauffenburger, Douglas, Alter, Galit

Get full text

The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs by Pepper, L. R., Cortese, J. F., Estiu, G., Galinsky, K., Zuzarte-Luis, V., Derbyshire, E. R., Ribacke, U., Lukens, A. K., Santos, S. A., Patel, V., Clish, C. B., Sullivan, W. J., Zhou, H., Bopp, S. E., Schimmel, P., Clardy, J., Mota, M. M., Keller, T. L., Whitman, M., Wiest, O., Wirth, D. F., Mazitschek, R., Lindquist, Susan, Herman, Jonathan D.

Get full text
Get full text
Get full text